Researchers design a therapeutic tool to inhibit the proliferation of the SARS-CoV-2 virus that causes COVID-19

The experts Verénica Noé and Carles J. Ciudad, at the the UB-s Faculty of Pharma
The experts Verénica Noé and Carles J. Ciudad, at the the UB-s Faculty of Pharmacy and Food Sciences.
A study led by the University of Barcelona and the Spanish National Research Council-s Institute for Advanced Chemistry of Catalonia (IQAC - CSIC) presents a new therapeutic tool capable of inhibiting the proliferation of the SARS-CoV-2 virus that causes COVID-19. The results open up new perspectives in the fight against this coronavirus and other viral diseases that still have no medical treatment, such as the Crimean-Congo haemorrhagic fever (CCHFV).

The paper, published on The Journal of Biological Chemistry, is led by experts Carlos J. Ciudad and Verónica Noé, from the UB-s Faculty of Pharmacy and Food Sciences and the Institute of Nanoscience and Nanotechnology (IN²UB), in collaboration with Ramon Eritja and Anna Aviñó, from the CSIC-s IQAC and the Bioengineering, Biomaterials and Nanomedicine Networking Biomedical Research Centre (CIBER-BBN). Researchers Miguel Chillón, from the Institute of Neuroscience of the Universitat Auténoma de Barcelona (INc - UAB) and Noemí Sevilla and José Manuel Rojas, from the Animal Health Research Centre (CISA - CSIC) have also played an important role. The study has also received the support of La Marató de TV3 2020, dedicated to promoting research against COVID-19.

Polypurine hairpins to inhibit the virus that causes COVID-19
-------

In May 2023, the World Health Organization declared that the COVID-19 pandemic was no longer a global emergency. However, many people worldwide are still infected by the SARS-CoV-2 virus.